Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

318 ARTÍCULOS , VIENDO DEL 166 AL 180

CORDIAL: cognitive rehabilitation and cognitive-behavioral treatment for early dementia in Alzheimer disease: a multicenter, randomized, controlled trial

Kurz A, Thöne-Otto A, Cramer B, Egert S, Frölich L, Gertz HJ, Kehl V, Wagenpfeil S, Werheid K.

Alzheimer Dis Assoc Disord. 2012 Jul-Sep;26(3):246-53. doi: 10.1097/WAD.0b013e318231e46e.

The effects of long-term omega-3 fatty acid supplementation on cognition and Alzheimer's pathology in animal models of Alzheimer's disease: a systematic review and meta-analysis

Hooijmans CR, Pasker-de Jong PC, de Vries RB, Ritskes-Hoitinga M.

J Alzheimers Dis. 2012;28(1):191-209. doi: 10.3233/JAD-2011-111217.

[The most cited work in the 36th year of "Psychiatrischen Praxis." Congratulations!]

Riedel-Heller SG.

Psychiatr Prax. 2012 Jan;39(1):3. doi: 10.1055/s-0031-1298836. Epub 2012 Jan 10.

Peptides for therapy and diagnosis of Alzheimer's disease

Funke SA, Willbold D.

Curr Pharm Des. 2012;18(6):755-67. doi: 10.2174/138161212799277752.

Interview for Deterioration in Daily Living Activities in Dementia: construct and concurrent validity in patients with mild to moderate dementia

Voigt-Radloff S, Leonhart R, Schützwohl M, Jurjanz L, Reuster T, Gerner A, Marschner K, van Nes F, Graff M, Vernooij-Dassen M, Rikkert MO, Holthoff V, Hüll M.

Int Psychogeriatr. 2012 Mar;24(3):382-90. doi: 10.1017/S1041610211001785.

Does pharmacological treatment of neuropsychiatric symptoms in Alzheimer's disease relieve caregiver burden?

Levy K, Lanctôt KL, Farber SB, Li A, Herrmann N.

Drugs Aging. 2012 Mar 1;29(3):167-179. doi: 10.2165/11599140-000000000-00000.

Symptomatic and nonamyloid/tau based pharmacologic treatment for Alzheimer disease

Aisen PS, Cummings J, Schneider LS.

Cold Spring Harb Perspect Med. 2012 Mar;2(3):a006395. doi: 10.1101/cshperspect.a006395.

Alzheimer's disease special thematic issue: call for papers

Georg GI, Wang S.

J Med Chem. 2012 Apr 12;55(7):2914. doi: 10.1021/jm300393h. Epub 2012 Mar 29.

Alzheimer's disease 2012: the great amyloid gamble

Marchesi VT.

Am J Pathol. 2012 May;180(5):1762-7. doi: 10.1016/j.ajpath.2012.03.004. Epub 2012 Apr 1.

Physical and cognitive stimulation in Alzheimer Disease. the GAIA Project: a pilot study

Maci T, Pira FL, Quattrocchi G, Nuovo SD, Perciavalle V, Zappia M.

Am J Alzheimers Dis Other Demen. 2012 Mar;27(2):107-13. doi: 10.1177/1533317512440493.

Ethical issues in Alzheimer's disease: an overview

Leuzy A, Gauthier S.

Expert Rev Neurother. 2012 May;12(5):557-67. doi: 10.1586/ern.12.38.

Increased cerebral metabolism after 1 year of deep brain stimulation in Alzheimer disease

Smith GS, Laxton AW, Tang-Wai DF, McAndrews MP, Diaconescu AO, Workman CI, Lozano AM.

Arch Neurol. 2012 Sep;69(9):1141-8. doi: 10.1001/archneurol.2012.590.

Efficacy and safety of donepezil 23 mg versus donepezil 10 mg for moderate-to-severe Alzheimer's disease: a subgroup analysis in patients already taking or not taking concomitant memantine

Doody RS, Geldmacher DS, Farlow MR, Sun Y, Moline M, Mackell J.

Dement Geriatr Cogn Disord. 2012;33(2-3):164-73. doi: 10.1159/000338236. Epub 2012 May 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias